Cancer Immunotherapy market Size, Industry Growth, COVID-19 Market to 2030

The researchers have considered all the factors influencing the growth of the Cancer Immunotherapy market on the global and regional scale. The report considers the COVID-19 pandemic as one of the key influencing factors of the Cancer Immunotherapy market. However, organizational concerns regarding data security is a key factor expected to hamper growth of the global Cancer Immunotherapy market over the forecast period. on the market.

The global Cancer Immunotherapy Market size was USD 119.39 Billion in 2021 and is expected to register a revenue CAGR of 14.0% during the forecast period, according to latest analysis by Emergen Research. The demand for cancer immunotherapy is anticipated to rise in the upcoming years as more people become aware of the various cancer treatment options. The primary driver for the cancer immunotherapy market is the anticipated increase in cancer incidence.

Rising need for gaining a full understanding of project processes and resource allocation is also expected to boost global  Cancer Immunotherapy Market growth over the forecast period.

To know more about

Key Players operating in the industry are:

  • The global market for cancer immunotherapy is divided into hospitals, cancer research institutes, and clinics based on end-use. In 2021, the hospital market contributed a sizeable portion of total revenue. This is explained by the rise in patient admissions. Most hospitals place a higher priority on addressing symptoms when it comes to cancer immunotherapy in particular. Modern cancer therapies are provided at these centres that boost patients’ immune systems. This group of pharmaceuticals includes cancer vaccinations, cellular therapies, and other experimental drugs. Hospitals continue to be the preferred medical location because they contain the most advanced technology for precise diagnosis and treatment. The level of medical care offered by hospitals has increased as a result of widespread use of innovative therapies, tests, and equipment, which is financed by both public and commercial sources.
  • The North American market for cancer immunotherapy accounted for the greatest revenue share in 2021. One of the main factors influencing the increase of market revenue is the existence of established industry players. The rapid uptake of immunotherapies in this area is also boosting market revenue. Improvements in the healthcare infrastructure, increased healthcare spending, and the availability of medical insurance in developed nations like the U.S. and Canada are further factors contributing to the market’s revenue growth. Due to the rise in cancer prevalence, the U.S. market accounted for the biggest revenue share.
  • The U.S. Food and Drug Administration (FDA) granted approval for CARVYKTI (ciltacabtagene autoleucel; cilta-cel) on February 28, 2022, for the treatment of adults with relapsed or resistant multiple myeloma (RRMM) following four or more prior lines of therapy, including proteasome inhibitor, immunomodulatory drug, and anti-CD38 monoclonal antibody.
  • Pembrolizumab, also known as Pembroxim, is an injection-only new medication that was released on July 29, 2020 by Bangladesh-based Beacon Medicare Limited (BML), to help patients combat the global spread of specific cancer types. The medication will be utilized in immunotherapy for melanoma, Hodgkin lymphoma, stomach, head, and neck malignancies. Injecting is suggested.

Some major companies in the global market report include:

Amgen, Inc., Astrazeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily and Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson & Johnson (Janssen Global Services, LLC), Merck KGAA, and Novartis AG.

Get Free Sample PDF Brochure@

Cancer Immunotherapy Market segmentation:

Technology Type Outlook (Revenue, USD Million; 2019-2030)

  • Monoclonal Antibodies
  • Cytokines & Immunomodulators
  • Others

End user Outlook (Revenue, USD Million; 2019-2030)

  • Hospitals
  • Cancer Research Centers
  • Clinics

Application Outlook (Revenue, USD Million; 2019-2030)

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

Regional Analysis Covers:

The Global   Cancer Immunotherapy Market is further analyzed across the key geographical locations where the market has expanded to a significant size. The key region analyzed are North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report offers a country-wise analysis to provide a comprehensive analysis of the   Cancer Immunotherapy market in terms of production and consumption patterns, supply and demand ratio, import/export, revenue contribution, trends, and presence of prominent players in each region.

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

The all-inclusive report on the Global   Cancer Immunotherapy Market added by Emergen Research demonstrates that the global   Cancer Immunotherapy market is presumed to grow at a steady CAGR throughout the forecast timeline. The report analyzed the key market drivers, restraints, growth opportunities, investment opportunities, threats, and limitations of the   Cancer Immunotherapy market. The report also offers accurate forecast estimation at a global and regional level to impart a better understanding of the scope of the market.

Click here to Get customization

Thank you for reading our report. Please get in touch with us if you have any query regarding the report or its customization. Our team will ensure the report is best suited to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Leave a Reply

Your email address will not be published. Required fields are marked *